Revive Therapeutics Ltd.
RVVTF
Price:
$0.0071
Market Cap:
$3.44M
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ tra...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-12-02
Stock Exchange
PNK
Ticker
RVVTF
The ROE as of September 2024 (TTM) for Revive Therapeutics Ltd. (RVVTF) is -41.98%
According to Revive Therapeutics Ltd.’s latest financial reports and current stock price. The company's current ROE is -41.98%. This represents a change of 298.36% compared to the average of -10.54% of the last 4 quarters.
Revive Therapeutics Ltd. (RVVTF) Historical ROE (quarterly & annually)
How has RVVTF ROE performed in the past?
The mean historical ROE of Revive Therapeutics Ltd. over the last ten years is -146.78%. The current -41.98% ROE has changed -71.40% with respect to the historical average. Over the past ten years (40 quarters), RVVTF's ROE was at its highest in in the September 2023 quarter at -3.81%. The ROE was at its lowest in in the March 2016 quarter at -198.55%.
Average
-146.78%
Median
-99.71%
Minimum
-481.49%
Maximum
-59.34%
Revive Therapeutics Ltd. (RVVTF) ROE by Quarter and Year
Discovering the peaks and valleys of Revive Therapeutics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 459.93%
Maximum Annual ROE = -59.34%
Minimum Annual Increase = -79.22%
Minimum Annual ROE = -481.49%
| Year | ROE | Change |
|---|---|---|
| 2023 | -59.34% | -58.00% |
| 2022 | -141.29% | 102.31% |
| 2021 | -69.84% | -3.59% |
| 2020 | -72.44% | -48.21% |
| 2019 | -139.87% | -35.87% |
| 2018 | -218.10% | 118.00% |
| 2017 | -100.04% | -79.22% |
| 2016 | -481.49% | 459.93% |
| 2015 | -85.99% | -13.46% |
| 2014 | -99.37% | -53.84% |
Revive Therapeutics Ltd. (RVVTF) Average ROE
How has RVVTF ROE performed in the past?
The current ROE of Revive Therapeutics Ltd. (RVVTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-90.16%
5-year avg
-96.56%
10-year avg
-146.78%
Revive Therapeutics Ltd. (RVVTF) ROE vs. Peers
How is RVVTF’s ROE compared to its peers?
Revive Therapeutics Ltd.’s ROE is greater than THC Biomed Intl Ltd. (-59.70%), greater than Vext Science, Inc. (-8.10%), less than New Leaf Ventures Inc (161.16%), greater than Pharmadrug Inc. (-1511.21%), less than High Fusion Inc. (53.55%), less than Green Cures & Botanical Distribution Inc. (89.83%), greater than Nextleaf Solutions Ltd. (-18.36%), less than GelStat Corporation (27.39%), less than Levitee Labs Inc. (0%), less than Choom Holdings Inc. (0%), greater than Avicanna Inc. (-6013.60%), greater than Wayland Group Corp. (-221.16%), greater than CV Sciences, Inc. (-89.87%), greater than Columbia Care Inc. (-230.99%), greater than Trulieve Cannabis Corp. (-7.49%), greater than Curaleaf Holdings, Inc. (-24.52%), less than Green Thumb Industries Inc. (3.80%), greater than The BC Bud Corporation (-92.69%), less than Amexdrug Corporation (0.09%), less than Aion Therapeutic Inc. (90.74%), less than Aspen Pharmacare Holdings Limited (0.30%), greater than Antisense Therapeutics Limited (-156.20%),
| Company | ROE | Market cap |
|---|---|---|
| -59.70% | $4.10M | |
| -8.10% | $46.66M | |
| 161.16% | $1.60M | |
| -1511.21% | $2.25M | |
| 53.55% | $767.56K | |
| 89.83% | $783.95K | |
| -18.36% | $9.72M | |
| 27.39% | $185.39K | |
| 0% | $369.15K | |
| 0% | $1.78M | |
| -6013.60% | $26.73M | |
| -221.16% | $23.70K | |
| -89.87% | $8.06M | |
| -230.99% | $521.35M | |
| -7.49% | $2.10B | |
| -24.52% | $2.20B | |
| 3.80% | $2.43B | |
| -92.69% | $382.77K | |
| 0.09% | $338.82K | |
| 90.74% | $2.80M | |
| 0.30% | $5.44B | |
| -156.20% | $245.95M |
Build a custom stock screener for Revive Therapeutics Ltd. (RVVTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revive Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Revive Therapeutics Ltd. (RVVTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Revive Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Revive Therapeutics Ltd.'s ROE?
How is the ROE calculated for Revive Therapeutics Ltd. (RVVTF)?
What is the highest ROE for Revive Therapeutics Ltd. (RVVTF)?
What is the 3-year average ROE for Revive Therapeutics Ltd. (RVVTF)?
What is the 5-year average ROE for Revive Therapeutics Ltd. (RVVTF)?
How does the current ROE for Revive Therapeutics Ltd. (RVVTF) compare to its historical average?